Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 191-200 of 236 for multiple myeloma

Edit search filters
  1. A Study To Assess A Change In Disease Activity And Adverse Events Of Intravenous Etentamig And Daratumumab (Etentamig+D) Compared To Daratumumab, Lenalidomide, And Dexamethasone (DRd) In Adult Participants With Newly Diagnosed Multiple Myeloma Not Eligible For Transplant

    Scottsdale/Phoenix, AZ, Rochester, MN

  2. Understanding the Challenges, Behavioral Patterns, and Preferences Towards Participation in Clinical Trials in Minority Patient Populations

    Jacksonville, FL, Scottsdale/Phoenix, AZ, Rochester, MN

  3. A Study to Evaluate Exercise for Cancer Patients at Risk of Falling

    Rochester, MN

  4. Study of Iopofosine I 131 (CLR 131) in Select B-Cell Malignancies (CLOVER-1) and Pivotal Expansion in Waldenstrom Macroglobulinemia (CLOVER-WaM)

    Jacksonville, FL

  5. Multiple Myeloma Patient Registry

    Jacksonville, FL

  6. Impact Of Restricted Medication Access On Care Of Multiple Myeloma Patients

    Rochester, MN

  7. Relating Clinical Outcomes in Multiple Myeloma to Personal Assessment of Genetic Profile

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  8. Comparison of MRI in the Evaluation of Multiple Myeloma

    Rochester, MN

  9. Development Of A Normal Hematologic Resource For The Aging Mechanisms In Myeloma, Amyloid, And Dysproteinemia Diseases

    Rochester, MN

  10. The Impact of Clinical Trials in Patients with Multiple Myeloma and Lymphoma

    Rochester, MN

.

Mayo Clinic Footer